Clorox (NYSE:CLX) Stock Price Target Lowered at Wells Fargo & Company

Key Points

• Wells Fargo lowered Clorox’s price target from $90 to $85 while maintaining an “equal weight” rating, implying approximately 4.54% upside from the stock’s reported $81.31 price.
• Analyst sentiment remains cautious: Clorox has an average “Reduce” rating and a consensus price target of $101.07, with 13 Hold and four Sell ratings; Wall Street Zen recently downgraded the stock to Sell.
• Clorox beat quarterly expectations with $1.66 in earnings per share versus $1.64 expected and $1.95 billion in revenue, though revenue declined 2% year over year and the stock remains well below its 52-week high of $128.90.

Clorox (NYSE:CLX - Get Free Report) had its price objective dropped by stock analysts at Wells Fargo & Company from $90.00 to $85.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has an "equal weight" rating on the stock. Wells Fargo & Company's target price suggests a potential upside of 4.54% from the company's current price.

A number of other research analysts also recently weighed in on the company. Wall Street Zen downgraded Clorox from a "hold" rating to a "sell" rating in a report on Saturday. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Clorox in a research report on Friday, July 10th. UBS Group reiterated a "neutral" rating on shares of Clorox in a research note on Friday, September 11th. Barclays reissued an "underweight" rating and issued a $84.00 price objective on shares of Clorox in a report on Tuesday, August 4th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Clorox from $92.00 to $95.00 and gave the company an "underweight" rating in a research report on Tuesday, August 4th. Thirteen equities research analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, Clorox currently has an average rating of "Reduce" and a consensus price target of $101.07.

Clorox Stock Performance

NYSE:CLX traded up $0.90 during trading hours on Monday, reaching $81.31. The company had a trading volume of 290,451 shares, compared to its average volume of 2,649,640. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. Clorox has a 52 week low of $79.12 and a 52 week high of $128.90. The firm has a market cap of $9.83 billion, a price-to-earnings ratio of 16.90, a PEG ratio of 2.52 and a beta of 0.59. The firm's 50 day moving average price is $95.63 and its 200-day moving average price is $96.72.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, beating analysts' consensus estimates of $1.64 by $0.02. The business had revenue of $1.95 billion during the quarter, compared to analyst estimates of $1.91 billion. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company's quarterly revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the business earned $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, analysts forecast that Clorox will post 5.8 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Kestra Private Wealth Services LLC raised its position in shares of Clorox by 1.8% in the 1st quarter. Kestra Private Wealth Services LLC now owns 5,957 shares of the company's stock valued at $617,000 after purchasing an additional 104 shares during the last quarter. Geneos Wealth Management Inc. grew its position in Clorox by 9.3% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company's stock worth $145,000 after purchasing an additional 119 shares during the last quarter. Root Financial Partners LLC grew its position in Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company's stock worth $33,000 after purchasing an additional 145 shares during the last quarter. Webster Bank N. A. increased its stake in Clorox by 61.2% during the 1st quarter. Webster Bank N. A. now owns 395 shares of the company's stock valued at $41,000 after purchasing an additional 150 shares in the last quarter. Finally, IFM Investors Pty Ltd increased its stake in Clorox by 0.6% during the 1st quarter. IFM Investors Pty Ltd now owns 24,284 shares of the company's stock valued at $2,517,000 after purchasing an additional 153 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

The Clorox Company is a consumer and professional products company that develops, manufactures and markets household cleaning, disinfecting, wellness and personal care products. Its portfolio includes the Clorox bleach and cleaning brands, as well as products sold under brands such as Pine-Sol, Liquid-Plumr, Fresh Step, Scoop Away, Kingsford, Hidden Valley, Burt's Bees and Brita.

Clorox also offers trash bags, food products, water-filtration systems, charcoal and grilling products, cat litter, and professional cleaning and disinfecting solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.